27 results
8-K
EX-10.1
XLO
Xilio Therapeutics Inc
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
of the Board.
(b)Annual Discretionary Bonus. Following the end of each calendar year beginning with the 2023 calendar year, the Executive … will be considered for an annual incentive bonus with respect to each fiscal year of the Executive’s employment with the Company. The amount, terms
8-K
XLO
Xilio Therapeutics Inc
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
of $370,000 and is eligible for an annual incentive bonus targeted at 35% of his base salary. Mr. Brennan is also eligible to participate in the employee
8-K
EX-10.1
XLO
Xilio Therapeutics Inc
3 Aug 23
Departure of Directors or Certain Officers
4:15pm
as set forth in Section 7(c)(i), is subject to increase (but not decrease) in the discretion of the Board.
(b) Annual Discretionary Bonus. Following … the end of each calendar year beginning with the 2022 calendar year, the Executive will be considered for an annual incentive bonus with respect to each
8-K
mokmj
3 Apr 23
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
gyz1 medpnn9hazvdf3
3 Apr 23
Departure of Directors or Certain Officers
4:05pm
S-3
EX-1.2
ozxk g795wx1nq8
9 Nov 22
Shelf registration
4:15pm
8-K
EX-10.1
fiir9v
16 Jun 22
Departure of Directors or Certain Officers
7:45am
DEF 14A
vpwk4f0qpg qbaw3zx9
26 Apr 22
Definitive proxy
4:05pm
10-K
EX-10.20
4pmja74v6ar24id6bkqa
1 Mar 22
Annual report
4:07pm
10-Q
marvr
2 Dec 21
Quarterly report
4:15pm
424B4
4w9ak48
22 Oct 21
Prospectus supplement with pricing info
4:02pm
S-1/A
EX-10.8
zzm4pclrx44eec0u
18 Oct 21
IPO registration (amended)
6:04am
S-1/A
vh2lp14uajvu
18 Oct 21
IPO registration (amended)
6:04am
S-1
rxkeot6
1 Oct 21
IPO registration
4:49pm
S-1
EX-10.18
e3e qedii
1 Oct 21
IPO registration
4:49pm
S-1
EX-10.20
eh7iq7ta4oaqd
1 Oct 21
IPO registration
4:49pm
S-1
EX-10.15
3g3609ho7l05n6 l2mfe
1 Oct 21
IPO registration
4:49pm